Susquehanna International Group, LLP Bristol Myers Squibb CO Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Susquehanna International Group, LLP holds 1,787,982 shares of BMY stock, worth $78.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,787,982
Previous 419,857
325.85%
Holding current value
$78.6 Million
Previous $25.6 Million
223.21%
% of portfolio
0.01%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding BMY
# of Institutions
2,674Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.57 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$6.97 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.75 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.16 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.11 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $93.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...